Article Versions Notes

Bazylevich A, Miller A, Tkachenko I, Merlani M, Patsenker L, Gellerman G, Lubin BCR. Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer. Pharmaceutics. 2024; 16(12):1613. https://doi.org/10.3390/pharmaceutics16121613

Bazylevich, Andrii, Ayala Miller, Iryna Tkachenko, Maia Merlani, Leonid Patsenker, Gary Gellerman, and Bat Chen R. Lubin. 2024. "Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer" Pharmaceutics 16, no. 12: 1613. https://doi.org/10.3390/pharmaceutics16121613

Bazylevich, A., Miller, A., Tkachenko, I., Merlani, M., Patsenker, L., Gellerman, G., & Lubin, B. C. R. (2024). Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer. Pharmaceutics, 16(12), 1613. https://doi.org/10.3390/pharmaceutics16121613